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Abstract 
Study design: Prospective multi-center cohort study. 
Objective: To study the question whetherparavertebral muscle qualitymay affect the clinical outcome of 
epidural steroid infiltration (ESI) or surgical decompression in patients with symptomatic lumbar spinal 
stenosis (LSS).  
Summary of Background Data: To the present, the impact of paravertebral muscle quality on clinical 
outcome of epidural steroid infiltration (ESI) or surgical decompression in patients with lumbar spinal 
stenosis (LSS) has not been clarified.   
Methods: The Lumbar Stenosis Outcome Study (LSOS) was used as database. Patients with symptomatic 
LSS who received an epidural steroid infiltration (group I) or lumbar decompression surgery (group II), 
had a follow up of at least 12 months and a pre-treatment lumbar MRI were included (n=205). 
Paravertebral muscle quality was quantified by the degree of fatty degeneration (according to Goutallier) 
on the level L3. Clinical outcome was assessed using the Spinal Stenosis Measure (SSM), Numeric 
Rating Scale (NRS), Roland and Morris Disability Questionnaire (RMDQ) and EQ-5D-3Lsum score. Re-
infiltration, surgery following infiltration, or revision was defined as treatment failure.  
Results: ESI (group I) and surgical treatment (group II) was associated with a failure rate of 60% and 
12.7%, respectively.  In group I, there was a tendencyfor the rate of re-intervention to be less in patients 
with bad muscle quality (p=0.22). In group II, improvements in the clinical outcomes up to 12 months 
did not differ between Goutallier stage ≤ 1 and ≥ 2. Patients with Goutallier stage ≤ 1 had more 
improvement in SSM symptoms (p=0.04). 
Conclusions: Relevant fatty degeneration of the paravertebral musculature, as a sign of low muscle 
quality, has low impact on clinical outcome and the high failure rates with conservative treatment by 
epidural steroid infiltration compared to surgical decompression. Therefore fatty degeneration has no 
relevant prognostic value for lumbar spinal stenosis treatment.  
Key Words: paravertebral muscle quality, impact, lumbar spinal stenosis, clinical outcome, 
decompression surgery, epidural steroid infiltration 
Level of Evidence: 2 
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INTRODUCTION 
Lumbar spinal stenosis (LSS) is one of the most commonly diagnosed and treated pathologies of the 
spine. In the general population the prevalence of absolute and relative degenerative LSS is 22.5% and 
7.3% respectively and increases with age.(1) 
Epidural steroid infiltration (ESI) and surgical decompression with or without fusion are established 
treatment options for symptomatic lumbar spinal stenosis (LSS).Results about efficiency of ESI are 
mixed. In some studies, a short term benefit could be confirmed, however most studies evaluating the 
long term benefit did not show superior outcome compared with physical 
therapy.(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)The long term success of surgical treatment varies between 45% and 72%. 
(12)A lower self-rated preoperative health-status, comorbidity, depression and limited, preoperative 
walking ability were identified as strong predictors of an unfavorable clinical outcome.(12)(13)(14) 
In 2010 the lumbar spinal stenosis study was launched with the aim to identify indicators predicting the 
future course of patients with lumbar spinal stenosis.(15) 
It seems obvious that the quality of paravertebral musculature, which represents an important support of 
the spinal column, would affect the outcome of LSS treatment. Dohzono et al recently showed an 
association between paravertebral muscle degeneration and the amount of sagittal imbalancewith low 
back pain.(16)(17) Further, the paravertebral muscles are innervated by dorsal branches of the spinal 
nerve roots. A causal relation between nerve fiber compression as it occurs in spinal stenosis, and 
alteration of the paravertebral muscles is plausible. (18)In considering these aspects we raised the 
question whether muscle quality, as reflected by fatty degeneration of the lumbar paravertebral 
musculature, may affect the clinical outcome and failure rate of epidural steroid infiltration or surgical 
decompression. 
  
MATERIALS AND METHODS 
  
Patient Selection and treatment strategies 
The Swiss lumbar stenosis outcome study (LSOS), which is a prospective multicenter cohort study of 
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patients with symptomatic degenerative lumbar spinal stenosis, was used as database (2010-2015). 
(15)The study was approved by the local ethical committee and conducted in accordance with the 
Declaration of Helsinki. All patients received written or oral information about the study and gave their 
written informed consent to participate. Patients with symptomatic LSS who received an epidural steroid 
infiltration (ESI, group I, n=40) or lumbar decompression surgery (Decompression, group II, n=165), 
who had a follow up of at least 12 months and a pre-treatment lumbar MRI were included (total n=205). 
Patients with evidence of stenosis caused by tumor, fracture, infection or significant deformity or any 
previous spinal surgeries were not included into the cohort.  
ESI was performed using contrast-enhanced fluoroscopy or CT-scan for guidance. Surgical 
decompression was performed with a standard open or microscopic posterior lumbar laminectomy or 
laminectomies. Fusion by pedicle screws with rods and intersomatic fusion and cage implantation was 
performed as revision for failed decompression surgery in cases of significant lumbar back pain or 
segmental instability.  
Re-infiltration, surgery following infiltration or revision surgery at the diseased segment was defined as 
treatment failure (Figure 1).  
 
Image analysis and assessment of paravertebral muscle quality  
MR imaging was performed in all patients included in the LSOS study. Due to the nature of a multicenter 
study, imaging was performed on different MRI scanners with field strengths at 1.5 and 3 T with varying 
scanning parameters. All imaging data from the participating clinical centers were collected at one place 
and therefore, saved on the picture archiving and communication system (PACS, IMPAX 6; AGFA 
Healthcare, Mortsel, Belgium) of the University hospital of city blinded for review process. (19) 
Two fellowship-trained musculoskeletal radiologists with 8 and 26 years of experience, who were 
blinded to clinical information and the results of the second reader, performed image analysis. Both 
radiologists had remote access to the PACS system and worked independently from different cities.(19) 
Paravertebral muscle quality was determined at baseline and quantified by the degree of fatty 
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degeneration on axial T2 weighted MR images on the level L3 according to the Goutallier/Fuchs 
classification system (20)(21): 0 = normal, no fatty streaks, 1 = some fatty streaks, 2 = important fatty 
streaks, but still more muscle than fat, 3 = as much fat as muscle, or 4 = more fat than muscle. Example 
images for fatty atrophy are provided in Figure 2A-E.  Intra- and inter-reader agreement for determining 
fatty degeneration was 0.87 and 0.45, respectively, and was reported in a former study by Winklhofer et 
al.(19) 
 
Clinical assessment 
Clinical outcome was assessed at baseline and at 12 months using the Spinal Stenosis Measure 
(SSM),Numeric Rating Scale (NRS), Roland and Morris Disability Questionnaire (RMDQ), EQ-5D-
3Lsum score and Cumulative Illness Rating Scale (CIRS). Data were in part interview-administered and 
recorded by a study coordinator. All other questionnaires were self-administered and filled in by the 
patients themselves.  
 
The SSM, an instrument specifically developed for spinal stenosis patients by Stucki et al.(22), targets to 
measure severity of symptoms and quantifies disability of the lumbar spinal stenosis population. It was 
already used in different studies on lumbar spinal stenosis(23)(24)(25)(26)and consists of three different 
subscales; the symptom severity subscale, the physical function subscale and the satisfaction subscale. 
The symptom severity scale can be divided into a pain domain (severity, frequency and back pain) and a 
neuroischemic domain (leg pain, weakness, numbness and balance disturbance). Score range is from 1-5 
and 1-4 (best-worst). 
The NRS serves for general assessment of lumbar spinal stenosis symptoms such as lower extremity pain 
and discomfort with ascore range from 0-10 (best-worst). 
The RMDQ is a back pain specific, self-rated physical disability questionnaire developed by Roland and 
Morris in 1983.(27)Disability is measured respective to the following categories: physical function 
activities and activities of daily living including eating and sleeping with a score range from 0-24 (best-
worst). 
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The EQ-5D-3L is an assessment tool to measure health-related quality of life. It measures general non-
disease specific health-related quality of life, including physical, mental and social dimensions.(28) The 
health status measures five dimensions of health (mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression) which can be calculated as a sum score (score range 0-100, worst-best).(28)The 
second part of the questionnaire estimates patient’s actual health status (score range 0-100, worst-best). 
The CIRS documents the presence and severity of comorbid diseases in 14 organ systems (according to a 
modified version by Miller et al.(29)) with a range from 0-56 (best-worst). The musculoskeletal organ 
system was separately included in the analysis.  
 
Minimal clinically important difference (MCID) 
The MCID is defined as “the smallest difference in a score that is considered to be worthwhile or 
important”.(30)Thus, the MCID is a threshold for a relevant change in an outcome measure. Patients who 
reached or even exceed this threshold consider this change as meaningful and worthwhile. According to 
Stucki et al.(22), MCID for SSM is reached when “Symptom Severity scale” improves at least 0.48 
points and “Physical Function scale” at least 0.52 points at follow-up. 
 
The primary outcome of the study was defined as changes in SSM symptoms and function. Secondary 
outcomes included MCID in SSM symptoms and function, and changes in NRS, EQ-5D-3L, and RMDQ. 
Further secondary outcome was the need for re-intervention (failure rate). 
 
Statistical Analyses 
All data were stored in a purpose-built database (Filemaker Pro 11, 2010; FileMaker Inc., Santa Clara, 
CA). Analysis of data consisted of descriptive statistics of patient demographics at baseline. Continuous 
variables were shown as mean and standard deviation, and categorical variables were shown as numbers 
and percentages of total, stratified by patients undergoing epidural infiltration (ESI, group I) or surgical 
treatment (group II), respectively. The non-parametric Wilcoxon test was used to compare changes in 
outcomes across Goutallier classification (≤ 1 / ≥ 2). To assess whether treatment failure was associated 
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with the Goutallier classification, the chi-squared test was used. Logistic regression was used to model 
MCID in SSM symptoms and SSM function, depending on Goutallier classification, age and treatment 
(surgical therapy versus epidural infiltration). Results were presented as odds ratios (OR) and confidence 
intervals (CI). 
The level of significance was set to α = 0.05. All analyses were conducted with R for Windows. (R Core 
Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical 
Computing, Vienna, Austria. URL http://www.R-project.org/.) 
 
RESULTS 
In this study, 205 patients were included; 40 patients were treated by epidural steroid infiltration (group I, 
ESI), 165 patients underwent decompression surgery (group II, decompression surgery). Operated levels 
were mainly L4/5 (42%), L3/4(35%) and L2/3 (13%), 109 patients (66%) underwent multi-level 
decompression. Baseline characteristics forage, gender and CIRS are presented in Table 1 and were 
comparable in both groups.  
In group I (ESI), 21 patients (52.5%) presented with good paravertebral muscle quality as defined by a 
Goutallier stage ≤1. Fatty degeneration stages ≥ 2 were found in 19 patients (47.5%). Reinfiltration or 
surgery following infiltration was necessary in 24 patients which corresponds to a failure rate of 60%. 
There was a tendency, though not significant, for the rate of re-intervention to be less in patients withbad 
muscle quality (Figure 1). The corresponding p-value of the chi-squared test was 0.22. 
In group II (Decompression), 112 patients (67.9%) presented with good paravertebral muscle quality 
(Goutallier stage ≤ 1) whereas fatty degeneration stages ≥ 2 were observed in 53 patients (32.1%). 21 
patients underwent reinfiltration or revision surgery which corresponds to a failure rate of 12.7%. There 
was no difference between patients with good or bad muscle quality (Figure 1). The corresponding p-
value of the chi-squared test was 0.81. 
There was a tendency towards better clinical outcomes (SSM subscales, NRS, RMDQ and EQ-5D-3L) in 
terms of improvement between baseline and 12 months follow-up in patients with Goutallier stage ≤ 1 as 
compared to Goutallier stage ≥ 2 (Table 2 and 3). However, these improvements did not differ 
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significantly, except for SSM symptoms (p=0.04) in group II. 
Multiple logistic regression models were fitted to MCID in SSM symptoms and SSM function at 12 
months. Results of the logistics regression models revealed that Goutallier ≥ 2 was associated with 
significantly lower chances for MCID in SSM symptoms (OR=0.47, 95% CI 0.25 to 0.88, p= 0.02). In 
the corresponding model for MCID in SSM function, the estimated OR was 0.85, however, the result was 
not statistically significant (p=0.61).Decompression surgery was associated with higher chances of 
MCID for SSM symptoms (OR = 1.34, 95% CI 0.64 to 2.82), and for SSM function (OR = 2.96, 95% CI 
1.44 to 6.10) (Table 4). 
 
DISCUSSION 
The results of our study indicate that relevant fatty degeneration of the paravertebral musculature 
(Goutallier stage ≥ 2), as a sign of low muscle quality, has low impact on failure rates and clinical 
outcomeof treatments with epidural steroid infiltration or decompression surgery. Surprisingly, Goutallier 
stage ≥ 2 tended to have lower rate of re-interventions in infiltrated patients, even if not reaching 
statistical significance. On the other hand, in both groups, Goutallier≥ 2 was associated with less 
postoperative improvement in most clinical scores.These findings might be due to potential limitations of 
the study.  
First, epidural steroid infiltration addresses chemical pain mechanisms, which are independent of muscle 
quality. It is postulated that corticosteroids reduce inflammation either by inhibiting the synthesis or 
release of a number of pro-inflammatory substances or by causing a reversible local anesthetic 
effect.(31)(32)Modes of action of steroids include membrane stabilization, inhibition of neural peptide 
synthesis or action, blockade of phospholipase A2 activity, prolonged suppression of ongoing neuronal 
discharge, and suppression of sensitization of dorsal horn neurons.(31)(32) 
Second, a follow-up of one year might be too short to find significant impact of fatty degeneration on 
clinical outcomes and a longer-term follow-up might reveal statistical significances in the here 
documented tendencies. However, a longer follow-up would be challenged by the increasing crossover 
rate of conservatively treated to surgical treated patients over time. Third, the paravertebral muscle 
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quality was measured only on the level L3. This disadvantage is mitigatedby a study conducted by 
Dohzono et al where in patients suffering from LSS no significant differences of fatty degeneration on 
different levels of the lumbar spine were observed.(16) Forth, spinopelvic parameters were not available 
for the evaluation of sagittal balance, which might be associated with lumbar back pain and could have 
introduced a bias. However, Bayerl et al showed that sagittal balance did not influence the clinical 
outcome of patients with lumbar spinal stenosis one year after surgical decompression.(33)Furthermore, 
it is well known that patients suffering from LSS lean forward to provide neural decompression by spinal 
canal widening in flexion.(34)Reactive improvement in the lumbar and global sagittal alignment can be 
induced by lumbar decompression surgery without fusion, even if sagittal imbalance exists 
preoperatively.(35) 
The low impact of muscle quality on clinical outcome as well as failure rate is surprising as different 
studies have demonstrated an association between paravertebral muscle degeneration and low back pain 
(LBP).(36)(37)(38) 
Nevertheless our results are in concordance with the study of Kalichman et al, which evaluated different 
features of spinal degeneration and their association with self-reported LBP. The only degenerative 
feature associated with self-reported LBP was spinal stenosis. Other degenerative features such as 
intervertebral disc degeneration, facet joint osteoarthritis, spondylolysis, spondylolisthesis and especially 
degeneration of the paravertebral muscles were not associated with the occurrence of LBP.(39) LBP is 
certainly not the only parameter determining the clinical outcome but is obviously represented in most 
questionnaires for clinical assessment of spinal pathologies.Furthermore the mean age of 75y (ESI) and 
73y (Decompression) may reduce the impact of musculature with respect to the general lower activity 
level, particularly strenous activity. 
 
Failure rate was lower in the surgical decompression group compared to the epidural steroid infiltration 
group and decompression surgery was associated with higher chance of MCID in SSM function. This 
finding is consistent with previous studies showing no relevant long-term improvement with epidural 
steroid infiltrations compared to physical therapy(11)(40), and the long term advantage of surgical 
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decompression in selected patients. (41) 
  
CONCLUSION 
Relevant fatty degeneration of the paravertebral musculature, as a sign of low muscle quality, has low 
impact on clinical outcome and the high failure rates with conservative treatment by epidural steroid 
infiltration compared to surgical decompression. Therefore fatty degeneration has no relevant prognostic 
value for lumbar spinal stenosis treatment. 
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FIGURE LEGENDS 
Figure 1. Patient flow: number of eligible patients (pts.) at baseline undergoing epidural steroid 
infiltration (ESI) or decompression surgery, subclassified in Goutallier ≤ 1 andGoutallier ≥ 2. 
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Figure 2. A-E. Series of axial T2 weighted MR images with increasing degree of fatty muscle 
degeneration at the level of L3.  
A. Goutallier grade 0 = normal, no fatty streaks;  
B. Goutallier grade 1 = some fatty streaks;  
C. Goutallier grade 2 = important fatty streaks, but still more muscle than fat;  
D. Goutallier grade 3 = as much fat as muscle;  
E. Goutallier grade 4 = more fat than muscle. 
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TABLE 1. Patients Characteristics 
 Total Population 
 
ESI Decompression 
Goutallier≤1 Goutallier≥2 Goutallier≤1 Goutallier ≥2 
n (%) 205 (100) 21 (52.5) 19 (47.5) 112 (67.9) 53 (32.1) 
Age, mean (sd) 74.1 (8.4) 75.0 (7.9) 73.8 (8.5) 
73.7 (8.9) 76.5 (6.5) 72.3 (9.1) 77.0 (6.1) 
Female, n (%) 112 (54.6) 21 (52.5) 91 (55.2) 
12 (57.1) 9 (47.4) 55 (49.1) 36 (67.9) 
CIRS, mean (sd) 9.1 (4.1) 8.9 (5.0) 9.1 (3.8) 
10.4 (6.0) 7.2 (2.9) 8.7 (3.6) 10.0 (4.2) 
Levels of laminectomy 
1 Level, n (%) 
 
> 1 Level, n (%) 
56 (33.9) 
40 (24.2) 16 (9.7) 
109 (66.1) 
72 (43.6) 37 (22.4) 
ESI indicates epidural steroid infiltration; CIRS cumulative illness rating scale 
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TABLE 2. Differences in the Swiss SSM Scores (Mean ± SD) between baseline (T0) and 12 months 
follow-up (T12) in patients treated with decompression and epidural steroid infiltration (ESI) 
subclassified in Goutallier ≤ 1 and Goutallier ≥ 2 
ESI Goutallier ≤ 1 (n=21) Goutallier ≥ 2 (n=19) p-
value T0 T12 Improvement T0 T12 Improvement 
SSM-symptom 
 
3.3 
(0.5) 
2.6 
(0.9) 
0.8 (0.9) 3.4 
(0.6) 
2.8 
(1.0) 
0.6 (1.1) 0.88 
SSM-function 
 
2.4 
(0.8) 
1.9 
(0.7) 
0.5 (0.9) 2.4 
(0.7) 
2.0 
(0.8) 
0.4 (1.0) 0.83 
 
Decompression Goutallier ≤ 1 (n=112) Goutallier ≥ 2 (n=53) p-
value T0 T12 Improvement T0 T12 Improvement 
SSM-symptoms 
 
3.2 
(0.6) 
2.1 
(0.8) 
1.1 (0.8) 3.2 
(0.7) 
2.3 
(0.9) 
0.8 (0.9) 0.04* 
SSM-function 
 
2.4 
(0.7) 
1.5 
(0.6) 
0.9 (0.8) 2.5 
(0.7) 
1.8 
(0.7) 
0.7 (0.8) 0.19 
ESI indicates epidural steroid infiltration; SSM Spinal stenosis measure 
 
p-values from Wilcoxon test. 
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TABLE 3. Differences in the Numeric Rating Scale (NRS), Roland Morris Disability Questionnaire (RMDQ), and 
EQ-5D (Mean ± SD) between baseline (T0) and 12 months follow-up (T12) in patients treated with decompression 
and epidural steroid infiltration (ESI) subclassified in Goutallier ≤ 1 and Goutallier ≥ 2 
ESI Goutallier ≤ 1 (n=21) Goutallier ≥ 2 (n=19) p-
value T0 T12 Improvement T0 T12 Improvement 
NRS 
 
7.5 (1.2) 4.6 (3.0) 3.0  
(3.2) 
6.6 (1.7) 4.1 (2.1) 2.6  
(3.3) 
0.88 
RMDQ 
 
12.2 (4.6) 10.4 
(6.8) 
1.8  
(4.8) 
14.8 (3.9) 10.8 (6.3) 4.0  
(6.3) 
0.30 
EQ-5D sum score 
 
64.3 (18.9) 74.8 
(18.3) 
-10.5  
(24.0) 
65.3 
(19.8) 
80.0 
(16.0) 
-14.7  
(28.2) 
0.66 
Decompression Goutallier ≤ 1 (n=112) Goutallier ≥ 2 (n=53) p-
value T0 T12 Improvement T0 T12 Improvement 
NRS 
 
6.3 (2.2) 2.9 (2.5) 3.4  
(3.1) 
7.0 (2.2) 3.5 (2.5) 3.5  
(3.3) 
0.89 
RMDQ 
 
12.2 (5.4) 7.0 (5.6) 5.2  
(5.6) 
14.0 (4.8) 9.1 (6.0) 5.0 
(5.7) 
0.79 
EQ-5D 
 
67.4 (17.2) 84.4 
(15.2) 
-16.9  
(19.8) 
60.9 
(15.7) 
77.2 
(16.9) 
-16.2  
(19.5) 
0.85 
ESI indicates epidural steroid infiltration 
 
 
p-value from Wilcoxon test. 
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TABLE 4. Estimated Odds Ratios for Meaningful Improvement From a Multiple Logistic Regression 
Model Including Goutallier Stage, Age and  
Decompression Surgery   
MCID SSM Symptoms 
 Odds ratio low95 hi95 p 
(Intercept) 3.40 0.19 62.36 0.409 
Goutallier≥ 2 0.47 0.25 0.88 0.019 
Age 1.00 0.96 1.03 0.822 
Decompression 1.34 0.64 2.82 0.434 
MCID SSM Function 
 Odds ratio low95 hi95 p 
(Intercept) 2.38 0.16 36.27 0.533 
Goutallier≥ 2 0.85 0.46 1.58 0.606 
Age 0.98 0.95 1.02 0.345 
Decompression 2.96 1.44 6.10 0.003 
MCID indicates minimal clinically important difference; SSM Spinal stenosis measure 
 
Odds ratio for clinically meaningful improvement 
 
 
 
Copyright © 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
